![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | (2006.01) |
A61K 9/0024 | (2013.01) | ||
A61K 9/14 | (2006.01) | ||
A61K 9/145 | (2013.01) | ||
A61K 9/146 | (2013.01) | ||
A61K 31/122 | (2006.01) | ||
A61M 31/002 | (2013.01) | ||
A61K 31/155 | (2006.01) | ||
A61K 31/198 | (2006.01) | ||
A61M 37/0069 | (2013.01) | ||
A61K 31/404 | (2006.01) | ||
A61P 25/16 | (2018.01) | ||
A61K 31/4458 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 31/485 | (2006.01) | ||
A61K 31/122 | (2013.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/155 | (2013.01) | ||
A61K 31/65 | (2006.01) | ||
A61K 31/198 | (2013.01) | ||
A61K 31/675 | (2006.01) | ||
A61K 31/404 | (2013.01) | ||
A61K 31/4458 | (2013.01) | ||
A61K 31/7068 | (2006.01) | ||
A61K 38/26 | (2006.01) | ||
A61K 31/485 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/506 | (2013.01) | ||
A61P 25/16 | (2006.01) | ||
A61K 31/65 | (2013.01) | ||
A61M 31/00 | (2006.01) | ||
A61K 31/675 | (2013.01) | ||
A61M 37/00 | (2006.01) | ||
A61K 31/7068 | (2013.01) | ||
A61K 38/26 | (2013.01) | ||
Y02A 50/30 | (2018.01) |
(11) | Number of the document | 3522825 |
(13) | Kind of document | T |
(96) | European patent application number | 17859227.5 |
Date of filing the European patent application | 2017-10-05 | |
(97) | Date of publication of the European application | 2019-08-14 |
(45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/055432 |
Date | 2017-10-05 |
(87) | Number | WO 2018/067882 |
Date | 2018-04-12 |
(30) | Number | Date | Country code |
201662404643 P | 2016-10-05 | US |
(72) |
PATEL, Rajesh A. , US
SREEDHARAN, Sunil , US
BHONSLE, Sunil R. , US
|
(73) |
TITAN PHARMACEUTICALS, INC. ,
400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080-1958,
US
|
(54) | IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE |
IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE |